Upgrade to SI Premium - Free Trial

Stifel Comments On Valeant (VRX) Earnings

May 9, 2017 10:25 AM
Stifel maintains Buy on Valeant Pharmaceuticals (NYSE: VRX) price target of $45.00.Analyst Annabel Samimy stands out as one of two ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles